Vertellus has signed a definitive agreement to acquire the potassium chloride, caustic pellets and vaccine adjuvant businesses of diversified US chemical firm Chemtrade. Terms were not disclosed. The transaction is expected to close during Q4, subject to regulatory approval and customary closing conditions.
Speciality chemicals firm Vertellus has been acquired from Arsenal Capital Partners by another private equity firm, Pritzker Private Capital of Chicago. John Van Hulle, president and CEO of Vertellus, and other members of the management team are also investing and will continue to lead the business. Terms were not disclosed